HomeHBP • TSE
add
Helix Biopharma Corp
Previous close
$0.89
Day range
$0.90 - $0.90
Year range
$0.50 - $1.35
Market cap
44.12M CAD
Avg Volume
5.56K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.59M | 27.32% |
Net income | -1.34M | -6.54% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.59M | -27.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 228.00K | -86.11% |
Total assets | 414.00K | -78.15% |
Total liabilities | 1.78M | 39.67% |
Total equity | -1.36M | — |
Shares outstanding | 49.02M | — |
Price to book | -29.67 | — |
Return on assets | -418.81% | — |
Return on capital | 548.14% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -1.34M | -6.54% |
Cash from operations | -861.00K | 53.51% |
Cash from investing | 8.00K | 166.67% |
Cash from financing | — | — |
Net change in cash | -853.00K | -202.40% |
Free cash flow | -532.88K | 61.51% |
About
Founded
1995
Headquarters
Website
Employees
7
